BLUE - Levi & Korsinsky Notifies bluebird bio Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – BLUE | Benzinga
NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in bluebird bio, Inc. ("bluebird bio" or the "Company") (NASDAQ:BLUE) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of bluebird bio investors who were adversely affected by alleged securities fraud between April 24, 2023 and December 8, 2023. Follow the link below to get more information and be contacted by a member of our team:
https://zlk.com/pslra-1/bluebird-bio-lawsuit-submission-form?prid=80179&wire=3
BLUE investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: According to the complaint, on December 8, 2023, Blue announced that the Food and Drug Administration (FDA) approved its ...